Subclinical primary aldosteronism. [PDF]
Parisien-La Salle S +4 more
europepmc +1 more source
ABSTRACT Introduction Weight loss results in reduced energy expenditure (EE) due to body composition alterations (e.g., fat‐free mass and fat mass losses) and mass‐independent adaptations in EE (e.g., hormones). Glucagon‐like peptide‐1 receptor agonists (GLP‐1RA) are indicated for obesity management; however, their effects on EE remain unclear ...
Flavio T. Vieira +8 more
wiley +1 more source
Direct Renin Inhibition With Aliskiren Compared to Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Hypertension: A Systematic Review. [PDF]
Gapizov A +6 more
europepmc +1 more source
Clinical management of bilateral functional adrenal adenomas. [PDF]
Melnyk B +4 more
europepmc +1 more source
The Renal Micro-Vasculopathy and Systemic Aldosterone-Renin Ratio (ARR) in Type 2 Diabetic Patients-A Retrospective Real-World Study. [PDF]
Wen S +10 more
europepmc +1 more source
Genetic Insights and Lifelong Management of Aldosterone Synthase Deficiency: A Case of Hyperreninemic Hypoaldosteronism. [PDF]
Ahmed MMH +4 more
europepmc +1 more source
Evaluating the effect of renin-angiotension-aldosterone system inhibitors and beta blockers on the progression of bicuspid aortic valve aortopathy in adulthood: A retrospective cohort study. [PDF]
Schamroth Pravda N +9 more
europepmc +1 more source
Renin report: spotlight on Renin: therapeutic opportunities for Renin inhibitors.
openaire +1 more source

